propafenone has been researched along with Gastric Diseases in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, WM | 1 |
| Chen, B | 1 |
| Cai, MH | 1 |
| Chen, Y | 1 |
| Zhang, YD | 1 |
1 trial available for propafenone and Gastric Diseases
| Article | Year |
|---|---|
The influence of CYP2D6 activity on the kinetics of propafenone enantiomers in Chinese subjects.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Area Under Curve; China; Cytochrome P-450 CYP2D | 1999 |